Detection and genetic diversity of parechoviruses in children with acute flaccid paralysis in Cameroon.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 24 12 2023
accepted: 21 03 2024
medline: 29 5 2024
pubmed: 29 5 2024
entrez: 29 5 2024
Statut: epublish

Résumé

Human Parechoviruses (HPeVs) have rarely been considered in the virological investigation of Acute Flacid Paralysis (AFP) cases in Africa, where enteric infections are very common. This study investigated the prevalence and genetic diversity of HPeV in 200 children aged ≤ 15 years with AFP in Cameroon from 2018 to 2019. HPeVs were detected in their faecal RNA using 5'-untranslated real-time RT-PCR. Detected HPeVs were typed by phylogenetic comparison with homologous sequences from homotypic reference strains. Overall, HPeV RNA was detected in 11.0% (22/200) of the 200 stool samples tested. Twelve HPeVs were successfully sequenced and reliably assigned to HPeV-A1, A4, A5, A10, A14, A15, A17 and A18 genotypes. Phylogenetic analyses revealed a high genetic variability among the studied HPeVs, as well as between the studied HPeVs and their previously reported counterparts from Cameroon in 2014. These findings suggest that different HPeV genotypes co-circulate in Cameroon without documented epidemics.

Identifiants

pubmed: 38809876
doi: 10.1371/journal.pone.0301771
pii: PONE-D-23-39966
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0301771

Informations de copyright

Copyright: © 2024 Njile et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Daniel Kamga Njile (D)

Department of Virology, Centre Pasteur of Cameroon, Yaoundé, Cameroon.
Faculty of Sciences, Department of Microbiology, University of Yaoundé 1, Yaounde, Cameroon.

Emmanuel Akongnwi Mugyia (EA)

Faculty of Science, Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon.

Marie Claire Endegue-Zanga (MC)

Department of Virology, Centre Pasteur of Cameroon, Yaoundé, Cameroon.

Jude Anfumbom Kfutwah (JA)

World Health Organization, Regional Office, Libreville, Gabon.

Marlise Dontsop Djoumetio (MD)

World Health Organization, Country Office, Yaoundé, Cameroon.

Boyomo Onana (B)

Faculty of Sciences, Department of Microbiology, University of Yaoundé 1, Yaounde, Cameroon.

Ousmane Madiagne Diop (OM)

Global Polio Eradication Initiative (GPEI), World Health Organization, Geneva, Switzerland.

Richard Njouom (R)

Department of Virology, Centre Pasteur of Cameroon, Yaoundé, Cameroon.

Serge Alain Sadeuh-Mba (SA)

Department of Virology, Centre Pasteur of Cameroon, Yaoundé, Cameroon.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH